Ilhan Omar actually said...
According to campaign for sustainable prescription drug pricing between 2017 and 2018 pharmaceutical companies more than doubled shareholder dividends while investing only 6 percent more in research and development.
Context
Omar highlights the disparity in pharmaceutical investment versus shareholder profits.
06/15/2021